In this review, we discuss the role and features of TME in NSCLC harboring EGFR-mutation focusing on the involvement of immunometabolism mechanisms mediated by CD39/CD73—adenosine signaling. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.